J. Robertson
Journal of Clinical Oncology · 2000–2015
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from J. Robertson's perspective
Ordered by how strongly the researchers J. Robertson trusts endorse each paper. Same corpus, a different order for every researcher.
- Tissue microarrays for rapid linking of molecular changes to clinical endpoints. (American Journal of Pathology)
- Expert Commentary. (Histopathology)
- Validation of Tissue Microarray Technology in Breast Carcinoma (Laboratory Investigation)
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular portraits of human breast tumours (Nature)
- The Nottingham prognostic index in primary breast cancer (Breast Cancer Research and Treatment)
- Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. (Science)
- Clinical prediction rules. Applications and methodological standards.
- Nuclear localization of EGF receptor and its potential new role as a transcription factor (Nature Cell Biology)
- Connections and Regulation of the Human Estrogen Receptor (Science)
Their papers
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. (2015) — 628 citations
- Expression of luminal and basal cytokeratins in human breast carcinoma (2004) — 615 citations
- Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study. (2000) — 868 citations